Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02656706
Title BrUOG 324: Adjuvant Nivolumab and Low Dose Ipilimumab for Stage III and Resected Stage IV Melanoma: A Phase II Brown University Oncology Research Group Trial
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors howard safran
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Rhode Island Hospital and The Miriam Hospital Providence Rhode Island 02903/02906 United States Details
*Shaded cells indicate that there was no data available from for the field